ClinConnect ClinConnect Logo
Search / Trial NCT00761813

Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)

Launched by UNIVERSITY OF MINNESOTA · Sep 26, 2008

Trial Information

Current as of August 27, 2025

Completed

Keywords

Sliding Hip Screw Fixation Cannulated Screw Fixation

ClinConnect Summary

One type of hip fracture, called a femoral neck fracture, involves a break in the narrow part of the femur bone where the head of the femur is joined to the main shaft. The break can be either undisplaced, which involves very little separation at the fracture site, or displaced, in which there is substantial separation. Surgeons agree that the best surgical procedure for an undisplaced fracture is internal fixation, in which a mechanical implant reconnects the two separated segments of bone. For displaced fractures, surgeons usually choose between internal fixation and a hip joint replaceme...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fracture of femoral neck
  • Operative treatment within 4 days for displaced fractures
  • Operative treatment within 7 days for nondisplaced fractures
  • Ambulatory before the injury
  • Low energy trauma, such as falls from a sitting or standing position
  • No other major trauma
  • Exclusion Criteria:
  • Unsuited for both surgical treatments
  • Associated major injuries of the lower extremities
  • Retained hardware around the hip
  • Infection around the hip
  • Bone metabolic disorder (except for osteoporosis)
  • Moderate or severe cognitive impairment
  • Parkinson's disease or dementia
  • Unable to complete the 2-year follow-up

About University Of Minnesota

The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.

Locations

Pittsburgh, Pennsylvania, United States

Philadelphia, Pennsylvania, United States

Greenville, South Carolina, United States

Boston, Massachusetts, United States

Cleveland, Ohio, United States

Dayton, Ohio, United States

Burlington, Massachusetts, United States

San Jose, California, United States

Temple, Texas, United States

Saint Louis, Missouri, United States

Fort Sam Houston, Texas, United States

Columbia, Missouri, United States

Birmingham, Alabama, United States

Indianapolis, Indiana, United States

Irvine, California, United States

Orange, California, United States

Denver, Colorado, United States

Grand Junction, Colorado, United States

Indianapolis, Indiana, United States

Grand Rapids, Michigan, United States

Saginaw, Michigan, United States

Minneapolis, Minnesota, United States

Saint Paul, Minnesota, United States

New Brunswick, New Jersey, United States

Rochester, New York, United States

Asheville, North Carolina, United States

Cincinnati, Ohio, United States

Youngstown, Ohio, United States

Nashville, Tennessee, United States

Lubbock, Texas, United States

San Antonio, Texas, United States

Spokane, Washington, United States

Patients applied

0 patients applied

Trial Officials

Marc Swiontkowski, MD

Principal Investigator

University of Minnesota

Mohit Bhandari, MD

Principal Investigator

McMaster University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials